Definium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 47,578 | 45,669 | 40,903 | 32,159 | 32,462 |
| Operating Income | -47,578 | -45,669 | -40,903 | -32,159 | -32,462 |
| Interest Expense | 1,268 | 1,274 | 2,338 | 602 | 656 |
| Other Income | -1,590 | -20,322 | 497 | 9,413 | -1,623 |
| Pre-tax Income | -50,436 | -67,265 | -42,744 | -23,348 | -34,741 |
| Net Income Continuous | -50,436 | -67,265 | -42,744 | -23,348 | -34,741 |
| Net Income | $-50,436 | $-67,265 | $-42,744 | $-23,348 | $-34,741 |
| EPS Basic Total Ops | -0.51 | -0.78 | -0.50 | -0.27 | -0.14 |
| EPS Basic Continuous Ops | -0.50 | -0.78 | -0.50 | -0.27 | -0.15 |
| EPS Diluted Total Ops | -0.43 | -0.78 | -0.50 | -0.35 | 0.13 |
| EPS Diluted Continuous Ops | -0.51 | -0.78 | -0.50 | -0.27 | -0.16 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.78 | -0.50 | -0.35 | -0.41 |
| EBITDA(a) | $-47,120 | $-45,526 | $-40,903 | $-32,159 | $-32,462 |